Literature DB >> 20811966

Application of method suitability for drug permeability classification.

Donna A Volpe1.   

Abstract

Experimental models of permeability in animals, excised tissues, cell monolayers, and artificial membranes are important during drug discovery and development as permeability is one of several factors affecting the intestinal absorption of oral drug products. The utility of these models is demonstrated by their ability to predict a drug's in vivo intestinal absorption. Within the various permeability models, there are differences in the performance of the assays, along with variability in animal species, tissue sources, and cell types, resulting in a variety of experimental permeability values for the same drug among laboratories. This has led to a need for assay standardization within laboratories to ensure applicability in the drug development process. Method suitability provides a generalized approach to standardize and validate a permeability model within a laboratory. First, assay methodology is optimized and validated for its various experimental parameters along with acceptance criteria for the assay. Second, the suitability of the model is demonstrated by a rank order relationship between experimental permeability values and human extent of absorption of known model compounds. Lastly, standard compounds are employed to classify a test drug's intestinal permeability and ensure assay reproducibility and quality. This review will provide examples of the different aspects method suitability for in situ (intestinal perfusions), ex vivo (everted intestinal sacs, diffusion chambers), and in vitro (cell monolayers, artificial membranes) experimental permeability models. Through assay standardization, reference standards, and acceptance criteria, method suitability assures the dependability of experimental data to predict a drug's intestinal permeability during discovery, development, and regulatory application.

Entities:  

Mesh:

Year:  2010        PMID: 20811966      PMCID: PMC2976984          DOI: 10.1208/s12248-010-9227-8

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  44 in total

Review 1.  Prediction of intestinal permeability.

Authors:  William J Egan; Georgio Lauri
Journal:  Adv Drug Deliv Rev       Date:  2002-03-31       Impact factor: 15.470

2.  Implementation of the caco-2 cell culture model as a predictive tool for the oral absorption of drugs. In-house evaluation procedures.

Authors:  F Ingels; S Deferme; N Delbar; M Oth; P Augustijns
Journal:  J Pharm Belg       Date:  2002 Nov-Dec

3.  Development of a 7-day, 96-well Caco-2 permeability assay with high-throughput direct UV compound analysis.

Authors:  Jochem Alsenz; E Haenel
Journal:  Pharm Res       Date:  2003-12       Impact factor: 4.200

4.  Validation of cell culture models for the intestine and the blood-brain barrier and comparison of drug permeation.

Authors:  Udo Bock; Thomas Flötotto; Eleonore Haltner
Journal:  ALTEX       Date:  2004       Impact factor: 6.043

5.  Drug absorption. I. An in situ rat gut technique yielding realistic absorption rates.

Authors:  J T Doluisio; N F Billups; L W Dittert; E T Sugita; J V Swintosky
Journal:  J Pharm Sci       Date:  1969-10       Impact factor: 3.534

6.  Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability.

Authors:  I J Hidalgo; T J Raub; R T Borchardt
Journal:  Gastroenterology       Date:  1989-03       Impact factor: 22.682

7.  Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells.

Authors:  P Artursson; J Karlsson
Journal:  Biochem Biophys Res Commun       Date:  1991-03-29       Impact factor: 3.575

8.  Mucosal in vitro permeability in the intestinal tract of the pig, the rat, and man: species- and region-related differences.

Authors:  P Nejdfors; M Ekelund; B Jeppsson; B R Weström
Journal:  Scand J Gastroenterol       Date:  2000-05       Impact factor: 2.423

9.  Predicting fraction dose absorbed in humans using a macroscopic mass balance approach.

Authors:  P J Sinko; G D Leesman; G L Amidon
Journal:  Pharm Res       Date:  1991-08       Impact factor: 4.200

10.  Characterization of jejunal absorption and apical efflux of ropivacaine, lidocaine and bupivacaine in the rat using in situ and in vitro absorption models.

Authors:  Sofia Berggren; Janet Hoogstraate; Urban Fagerholm; Hans Lennernäs
Journal:  Eur J Pharm Sci       Date:  2004-03       Impact factor: 4.384

View more
  19 in total

Review 1.  Nanoparticles for oral delivery: Design, evaluation and state-of-the-art.

Authors:  Abhijit A Date; Justin Hanes; Laura M Ensign
Journal:  J Control Release       Date:  2016-06-09       Impact factor: 9.776

2.  The effects of intralaboratory modifications to media composition and cell source on the expression of pharmaceutically relevant transporters and metabolizing genes in the Caco-2 cell line.

Authors:  Wyatt J Roth; David J Lindley; Stephen M Carl; Gregory T Knipp
Journal:  J Pharm Sci       Date:  2012-07-11       Impact factor: 3.534

Review 3.  Bioequivalence of oral products and the biopharmaceutics classification system: science, regulation, and public policy.

Authors:  K S Amidon; P Langguth; H Lennernäs; L Yu; G L Amidon
Journal:  Clin Pharmacol Ther       Date:  2011-07-20       Impact factor: 6.875

4.  In Vitro and In Situ evaluation of pH-dependence of atazanavir intestinal permeability and interactions with acid-reducing agents.

Authors:  Olena Kis; Sharon L Walmsley; Reina Bendayan
Journal:  Pharm Res       Date:  2014-03-05       Impact factor: 4.200

5.  Hot melt extrusion as an approach to improve solubility, permeability and oral absorption of a psychoactive natural product, piperine.

Authors:  Eman A Ashour; Soumyajit Majumdar; Abdulla Alsheteli; Sultan Alshehri; Bader Alsulays; Xin Feng; Andreas Gryczke; Karl Kolter; Nigel Langley; Michael A Repka
Journal:  J Pharm Pharmacol       Date:  2016-06-10       Impact factor: 3.765

6.  Intestinal Permeability and Oral Absorption of Selected Drugs Are Reduced in a Mouse Model of Familial Alzheimer's Disease.

Authors:  Liang Jin; Yijun Pan; Natalie Lan Linh Tran; Leon N Polychronopoulos; Aparna Warrier; Kim L R Brouwer; Joseph A Nicolazzo
Journal:  Mol Pharm       Date:  2020-04-08       Impact factor: 4.939

7.  Eremantholide C from aerial parts of Lychnophora trichocarpha, as drug candidate: fraction absorbed prediction in humans and BCS permeability class determination.

Authors:  Tamires Guedes Caldeira; Dênia Antunes Saúde-Guimarães; Isabel González-Álvarez; Marival Bermejo; Jacqueline de Souza
Journal:  Daru       Date:  2021-04-22       Impact factor: 3.117

8.  Inhibition of P-glycoprotein expression and function by anti-diabetic drugs gliclazide, metformin, and pioglitazone in vitro and in situ.

Authors:  Mehran Mesgari Abbasi; Hadi Valizadeh; Hamed Hamishehkar; Parvin Zakeri-Milani
Journal:  Res Pharm Sci       Date:  2016 May-Jun

9.  Study on biopharmaceutics classification and oral bioavailability of a novel multikinase inhibitor NCE for cancer therapy.

Authors:  Yang Yang; Chun-Mei Fan; Xuan He; Ke Ren; Jin-Kun Zhang; Ying-Ju He; Luo-Ting Yu; Ying-Lan Zhao; Chang-Yang Gong; Yu Zheng; Xiang-Rong Song; Jun Zeng
Journal:  Int J Mol Sci       Date:  2014-04-25       Impact factor: 5.923

10.  In vitro-in vivo Pharmacokinetic correlation model for quality assurance of antiretroviral drugs.

Authors:  Ricardo Rojas Gómez; Piedad Restrepo Valencia
Journal:  Colomb Med (Cali)       Date:  2015-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.